The Africa Centers for Disease Control and Prevention (Africa CDC) has officially welcomed the landmark approval of the first malaria treatment specifically designed for infants, calling it a “major step forwards” in the relentless battle against the disease.
The new treatment is a dedicated formulation for newborns and infants weighing less than five kilograms (11 pounds), a vulnerable demographic that has historically lacked optimized anti-malarial medications. This development addresses a critical gap in pediatric healthcare across the continent, where malaria remains a leading cause of childhood illness and death.
The breakthrough was achieved through a collaborative partnership between the Swiss pharmaceutical giant Novartis and the non-profit product development partnership, Medicines for Malaria Venture (MMV). The Swiss drug regulatory body granted formal approval for the treatment in July.
In a press release, the Africa CDC extended praise to the eight member states where the clinical trials for the medicine were successfully conducted. These nations include Burkina Faso, Ivory Coast, Kenya, and Nigeria. The organization highlighted that the pivotal role these countries played “underscores Africa’s growing role in driving health innovation” from within.
The urgent need for this medical advancement is underscored by devastating statistics. According to the World Health Organization, malaria was responsible for nearly 600,000 deaths globally in 2023, with the majority being young children in Africa.
The rollout of the treatment is expected to be swift. The Africa CDC announced that the new medicine is anticipated to be introduced in the eight African trial countries within the coming weeks. The organization has pledged its continued collaboration with member states to ensure widespread and equitable access.
“The Africa CDC said it would continue working with the member states involved to ensure that every child gets access to the treatment,” the statement read, signaling a firm commitment to translating this scientific achievement into tangible health outcomes for the continent’s youngest and most vulnerable citizens.
About Africa CDC: The Africa CDC is a public health agency of the African Union dedicated to strengthening the capacity of Africa’s public health institutions to detect and respond quickly and effectively to disease threats and outbreaks.
